Anna Alvarez-Guaita

Anna Alvarez-Guaita

Auto-generated profile, based on publicly available information

Anna Alvarez-Guaita

Unit of Cell Biology, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences University of Barcelona Spain

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 June 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
SPSatish Patel
Satish Patel
AHAfreen Haider
Afreen Haider
AAAnna Alvarez-Guaita
Anna Alvarez-Guaita
GBGuillaume BIDAULT
Guillaume BIDAULT
JMJulia Sarah El-Sayed Moustafa
Julia Sarah El-Sayed Moustafa
DSDavid B. Savage
David B. Savage
Summary: Obesity in mice and humans is associated with elevated levels of at least two hormones responsive to cellular stress, namely GDF15 and FGF21. Over-expression of each of these is associated with weight loss and beneficial metabolic changes but where they are secreted from and what they are required for physiologically in the context of overfeeding remains unclear. Here we used tissue selective knockout mouse models to establish that, like FGF21, circulating GDF15 is primarily derived from the liver, rather than adipose tissue, muscle or macrophages in high fat fed mice. Combined whole body deletion of FGF21 and GDF15 does not result in any additional weight gain in high fat fed mice but is associated with significantly greater hepatic steatosis and insulin resistance. Collectively the data suggest that activation of the integrated stress response in hepatocytes is a major driver for GDF15 and FGF21 secretion in the context of overfeeding, and that they both act to alleviate this metabolic stress.

13 August 2025 in Journal of Cellular Physiology
Verified
Journal Article
Open access
AAAnna Alvarez‐Guaita
Anna Alvarez‐Guaita
MBMarc Bernaus-Esqué
Marc Bernaus-Esqué
PBPatricia Blanco‐Muñoz
Patricia Blanco‐Muñoz
YLYangjing Liu
Yangjing Liu
David SebastiánDavid Sebastián
David Sebastián
CRCarles Rentero
Carles Rentero
Maintaining constant blood glucose levels is essential for energizing glucose‐dependent tissues. During the fed state, insulin lowers elevated blood glucose, while in the fasted state, glucagon maintains blood glucose levels through hepatic stimulation of fatty acid oxidation, glycogenolysis, and gluconeogenesis (GNG). The liver plays a crucial role in these metabolic adaptations. Deregulation of GNG is a hallmark of type 2 diabetes mellitus (T2DM), driven by hepatic insulin resistance, elevated glucagon levels, and excess circulating free fatty acids. The glucose metabolism of 8‐ to 12‐week‐old WT and Anxa6 knock‐out (Anxa6−/−) mice was analysed during regular feeding and fasting using indirect calorimetry, tolerance tests and biochemical analysis. Despite normal insulin‐sensitive control of glucose levels and effective glycogen mobilization, Anxa6−/− mice display rapid hypoglycaemia during fasting. This metabolic disarrangement, in particular during the early stages of fasting is characterized by a low respiratory exchange ratio (RER) and increased lipid oxidation during the diurnal period, indicating a reliance on lipid oxidation due to hypoglycaemia. Elevated glucagon levels during fasting suggest deficiencies in GNG. Further analysis reveals that Anxa6−/− mice are unable to utilize alanine for hepatic GNG, highlighting a specific impairment in the glucose‐alanine cycle in fasted Anxa6−/− mice, underscoring the critical role of ANXA6 in maintaining glucose homeostasis under metabolic stress. During fasting, slightly reduced expression levels of alanine aminotransferase 2 (Gpt2) and lactate dehydrogenase (Ldha2), enzymes converting alanine to pyruvate, and the hepatic alanine transporter SNAT4 might contribute to these observations in the Anxa6−/− mice. These findings identify that ANXA6 deficiency causes an inability to maintain glycolytic metabolism under fasting conditions due to impaired alanine‐dependent GNG.

26 January 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
AAA Alvarez-Guaita
A Alvarez-Guaita
MBMarc Bernaus-Esqué
Marc Bernaus-Esqué
PBP Blanco-Muñoz
P Blanco-Muñoz
YLY Liu
Y Liu
DSD Sebastian
D Sebastian
CRCarles Rentero
Carles Rentero
Maintaining constant blood glucose levels is essential for energizing glucose-dependent tissues. During the fed state, insulin lowers elevated blood glucose, while in the fasted state, glucagon maintains blood glucose levels through hepatic stimulation of fatty acid oxidation, glycogenolysis, and gluconeogenesis (GNG). The liver plays a crucial role in these metabolic adaptations. Deregulation of GNG is a hallmark of type 2 diabetes mellitus (T2DM), driven by hepatic insulin resistance, elevated glucagon levels, and excess circulating free fatty acids. Despite normal insulin-sensitive control of glucose levels and effective glycogen mobilization, Anxa6 knockout ( Anxa6 − / − ) mice display rapid hypoglycaemia during fasting. This metabolic disarrangement, in particular during the early stages of fasting is characterized by a low respiratory exchange ratio (RER) and increased lipid oxidation during the diurnal period, indicating a reliance on lipid oxidation due to hypoglycaemia. Elevated glucagon levels during fasting suggest deficiencies in GNG. Further analysis reveals that Anxa6 − / − mice are unable to utilize alanine for hepatic GNG, highlighting a specific impairment in the glucose-alanine cycle in fasted Anxa6 − / − mice, underscoring the critical role of ANXA6 in maintaining glucose homeostasis under metabolic stress. During fasting, slightly reduced expression levels of alanine aminotransferase 2 ( Gpt2 ) and lactate dehydrogenase ( Ldha2 ), enzymes converting alanine to pyruvate, and the hepatic alanine transporter SNAT4 might contribute to these observations in the Anxa6 − / − mice. These findings identify that ANXA6 deficiency causes an inability to maintain glycolytic metabolism under fasting conditions due to impaired alanine-dependent GNG.